Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (281-290 of 451) with videos related to

Pageof 46
Sort By:
Theranostics|April 17, 2026
Voxel-accurate MRI-microscopy Correlation Enables AI-powered Prediction of Brain Disease StatesJulian Schroers, Yvonne Yang, Ekin Reyhan, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Nature Medicine|September 22, 2023
A H3K27M-targeted vaccine in adults with diffuse midline gliomaNiklas Grassl, Isabel Poschke, Katharina Lindner, et al.
Acta Neuropathologica|November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningiomaPhilipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Nature Medicine|September 5, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N<sup>2</sup>M<sup>2</sup> umbrella trialWolfgang Wick, Lisa-Marie Lanz, Antje Wick, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Clinical Sarcoma Research|May 10, 2017
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated casesChristian Koelsche, Daniel Schrimpf, Lars Tharun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2018
Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic informationChristian Koelsche, Wolfgang Hartmann, Daniel Schrimpf, et al.
International Journal of Cancer|March 28, 2018
A PRDX1-p38α heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomasPeter Wirthschaft, Julia Bode, Anika E M Simon, et al.
Pageof 46

Showing results (281-290 of 451) with videos related to

Sort By:
Pageof 46
Theranostics|April 17, 2026
Voxel-accurate MRI-microscopy Correlation Enables AI-powered Prediction of Brain Disease StatesJulian Schroers, Yvonne Yang, Ekin Reyhan, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Nature Medicine|September 22, 2023
A H3K27M-targeted vaccine in adults with diffuse midline gliomaNiklas Grassl, Isabel Poschke, Katharina Lindner, et al.
Acta Neuropathologica|November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningiomaPhilipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Nature Medicine|September 5, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N<sup>2</sup>M<sup>2</sup> umbrella trialWolfgang Wick, Lisa-Marie Lanz, Antje Wick, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Clinical Sarcoma Research|May 10, 2017
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated casesChristian Koelsche, Daniel Schrimpf, Lars Tharun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2018
Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic informationChristian Koelsche, Wolfgang Hartmann, Daniel Schrimpf, et al.
International Journal of Cancer|March 28, 2018
A PRDX1-p38α heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomasPeter Wirthschaft, Julia Bode, Anika E M Simon, et al.
Pageof 46